Auren Rx Review: $199 Semaglutide, $299 Tirzepatide

Auren Rx (aurenrx.com) sells ten prescription products and does something no other row here does: it publishes two prices for every single one of them — a discounted subscription rate and an explicit "monthly, no commitment" rate — on the same page, side by side. We checked it in August 2026. The pricing structure is the cleanest in a batch of seven providers. The disclosure record has one large hole in it.

The GLP-1 ladder

There are two GLP-1 programs, standard and microdose, across both molecules. Standard semaglutide is $169 a month subscribed and $199 month-to-month. Standard tirzepatide is $259 subscribed and $299 month-to-month. Microdose semaglutide is $129 subscribed and $149 month-to-month; microdose tirzepatide is $229 subscribed and $250 month-to-month.¹

We file the month-to-month figures — $199 and $299 — because that is what you pay if you do not commit, and because two separate things on this site will hand you a different number if you are not careful.

Two ways to capture the wrong price here

The first: the weight-loss page loads with tirzepatide already selected. Open it, glance at the price, and you have recorded $299 as "the Auren Rx price" when semaglutide is $199. That is not hypothetical — it is the single most common shifted-column error in provider price capture, and this site is live proof of it.

The second: the site's own structured data publishes the subscribe rung, not the monthly one. Anything that reads a page's Product markup instead of its rendered table will file $169 and $259 as Auren Rx's prices. Both are real numbers; neither is the no-commitment price. If you see Auren Rx quoted at $169 somewhere, that is why.

There is a third, smaller one. The navigation reads "Semaglutide and Tirzepatide from $129/mo". The $129 is the microdose semaglutide subscribe rung. The cheapest standard GLP-1 rung is $169 subscribed, $199 monthly — $70 a month more than the nav implies. The number is not invented, but the heading it sits under is doing work.

The microdose program is a real program

Unlike most operators who mention microdosing, Auren Rx runs it as a named product with its own page, its own intake and its own four-rung price table across both molecules. That is a structural commitment rather than a marketing line. It is also the reason we would send anyone specifically shopping low-dose GLP-1 here first — with the standing caveat in GLP-1 microdosing that no randomized trial has tested below-label dosing, so a well-organized microdose program is still a well-organized untested one.

The rest of the shelf

NAD+ is the deepest line: seven rungs across injection, nasal spray and cream, each with strength and volume stated — $209 monthly for the 100 mg/mL injection, $169 to $249 monthly across four nasal options, $155 and $215 for the two cream sizes.¹ Sermorelin is $199 monthly, glutathione $119 injectable and $109 nasal, GHK-Cu cream $109, tretinoin $49, oral minoxidil $49, valacyclovir $39 to $49, estradiol $69 to $99. There is no research-chemical shelf, no retatrutide, no melanotan, no testosterone.

Two of those products — valacyclovir and estradiol — are not in the site's own sitemap. Reading the sitemap alone would tell you they do not exist.

What is not disclosed

Auren Rx never publishes the states it operates in. Its terms say services are available to individuals located in "certain states" and in "a state where we operate", and the states are never listed anywhere on the site. Every other provider in this batch either publishes a list or claims all 50. This is the biggest gap in an otherwise strong record, and it matters most if you are in a state with restrictive telehealth rules, because you will not find out until you are in the intake.

The pharmacy is also unnamed — described as "Auren RX or one of our partner pharmacies". You may elect a local pharmacy instead, in which case the membership fee excludes the medication cost. No individual prescriber is named. Clinical services are attributed to Beluga Health, P.A., a real telehealth professional association, and the corporate entity is Hades Capital LLC doing business as Auren RX, with no published address.

Fees, billing and cancellation

The membership fee is charged the day membership commences and is non-refundable once paid. Membership begins after a provider communicates a care plan and you elect to proceed, so it follows clinical review rather than preceding it — which is better than the alternative and better than several providers in this batch. Billing is described as approximately every 28 to 30 days, which is slightly short of a calendar month but disclosed, unlike Vyvron, whose undisclosed four-week cycle produces thirteen charges a year. Cancellation is month-to-month by email or in-account, and membership can be paused with no further charges until you order a refill.

Product pages show 4.6 to 4.9 star ratings with no review count and no source. We do not repeat those.

The regulatory screen

The trading name, the legal entity, the medical group and the platform vendor all returned zero company-column matches in the FDA's live warning-letter index in August 2026.² The pass included a positive control that correctly returned a known 2026 letter for an unrelated telehealth seller, so the clean result is evidence rather than a failed query.

Where it lands

On structure, Auren Rx is the best-built price surface in this batch — a no-commitment rung on every SKU, granular NAD+ options, correctly labeled billing cadence, no prepay tier to disguise anything. On disclosure it has one specific failure, and it is not a small one: you cannot find out whether it serves your state without starting an intake. Weigh those against each other with how to choose a GLP-1 provider, the rest of our evidence library, and the alternatives at The Edit and Trellis Vitality.